GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / Articles / GHTM Master’s student wins EUTOPIA PhD Co-tutelle Programme

GHTM Master’s student wins EUTOPIA PhD Co-tutelle Programme

22 Junho, 2022

The project called “PADRE: Predicting Antiviral Drug Resistance before its Emergence”, developed by Professor Dr. Ana Abecasis and by the Master student Francisco Merca, of the TB, HIV and opportunistic diseases and pathogens (THOP) group, from Global Health and Tropical Medicine (GHTM), got accepted by the 2022 call of the EUTOPIA alliance PhD-Co tutelle programme. This project will be developed in collaboration with Professor Pieter Libin, from the Vrije Universiteit Brussels (VUB) (Department of Artificial Intelligence). As a project developed between the two universities, it will strengthen institutional ties.

“PADRE: Predicting Antiviral Drug Resistance before its Emergence”, consists of developing a computational machine learning tool, for the prediction of antiretroviral drug resistance development in treated HIV populations. As antiretroviral drugs are one important tool to combat HIV transmission and prevent mortality in HIV-positive individuals, antiretroviral drug resistance is one important problem to be tackled. To combat this problem, it is important to be a step ahead of this problem by prediction computational approaches. With the recent advances in artificial intelligence, it is possible to study drug resistance through a combination of computational methods that take into account viral evolution, protein structures and molecular docking. This would facilitate the pre-screening and design of antiretrovirals through anticipating mutational pathways of future HIV viral strains, that could cause resistance to existing drugs. Combined with recent advances in in silico drug design and discovery, this could lead to a novel approach to minimize the likelihood of resistance emergence immediately upon development and design.

The impact of this project can be huge, both in terms of health outcomes, by reducing the morbidity and mortality attributed to antiviral drug resistance, but also economically, contributing to smart molecule design and therefore the development of more effective drugs, allowing to save resources to the pharmaceutical companies during the drug development process. Furthermore, it allows saving money to national health systems related to switches in therapeutic regimens.

This project was one of the 17 projects selected for the 2022 EUTOPIA PhD Co-Tutelle programme. The participating members of the EUTOPIA alliance are: CT Cergy Paris Université (co-ordinators), Vrije Universiteit Brussels, University of Warwick, University of Bolyai-Babes, NOVA University and University of Ca´Foscari.

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to print (Opens in new window)

Events

NOVA Sciencepreneur program: registration is open

  The Sciencepreneur ® program is aimed at NOVA scientists who are seeking to create value … [Read More...]

IHMT selected for the pilot phase of the Research Data Repository Service of the FCT

  In order to promote good practices in Open Science with regard to research data and … [Read More...]

Paulo Ferrinho interviewed for the new e-magazine of European and Developing Countries Clinical Trials Partnership (EDCTP)

Paulo Ferrinho, professor and Diretor of Public Global Health Departament at the Instituto de … [Read More...]

How can we improve the environmental performance of our laboratories?

  Every day in NOVA's laboratories research is carried out with the consumption of numerous … [Read More...]

Call for PhD Studentships

The Institute of Hygiene and Tropical Medicine (IHMT), Universidade Nova de Lisboa (NOVA), through … [Read More...]

IHMT | GHTM – APPLICATIONS ARE OPEN!

IHMT | GHTM - Applications are open for three research vacancies:   One position - PhD … [Read More...]

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013

 

Loading Comments...